@FiercePharma: Top read on FP Marketing Weds: Men's Health Week or Low-T Week? Critics say awareness campaign is another pharma ploy. Article | Follow @FiercePharma
@TracyStaton: Trending at FiercePharmaMarketing: Do reps push drugs off-label? Study says yes. Does it work? Also yes. Story | Follow @TracyStaton
@EricPFierce: FDA says compounder making drugs under unsanitary conditions. More | Follow @EricPFierce
@CarlyHFierce: Merck's RotaTeq, Glaxo's Rotarix cut hospitalizations by up to 94%. FierceVaccines story | Follow @CarlyHFierce
@JustinHFierce: Some pet owners are becoming anti-vaxxers too, new trend sparks fears in vets over rabies surge. More from ABC | Follow @JustinHFierce
> Eli Lilly ($LLY) recruited Ora Pescovitz, former CEO of the University of Michigan Health System, to be a senior vice president, beginning in October. Report
> A New York federal judge whittled away at a False Claims Act lawsuit against Novartis ($NVS) and several specialty pharmacies over alleged kickbacks designed to boost sales of its leukemia drugs Gleevec and Tasigna. Report
> Auxilium Pharmaceuticals ($AUXL) said it partnered with Prasco to roll out an authorized generic version of its testosterone gel Testim. Report
> New long-term data on UCB's anti-inflammatory drug Cimzia showed improved outcomes in patients with spondyloarthritis. Release
> An Australian consumer watchdog group takes issue with the pricing on "premium versions" of common painkillers made by GlaxoSmithKline ($GSK) and Reckitt Benckiser. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: AbbVie to co-promote hep C diagnostic. Story | Follow @FierceMedDev
@StacyALawrence: Medtronic readies for 2015 drug-eluting balloon FDA approval. More | Follow @StacyALawrence
@MichaelGFierce: UCSB study: New silver nanoparticles dissolve if they don't hit their mark. FierceDrugDelivery story | Follow @MichaelGFierce
@EmilyWFierce: Mobile medical app brings laboratory testing to the home. Story | Follow @EmilyWFierce
> Withdrawn submissions are new focus for FDA med device review process. More
> FDA gives nod to Covidien's detachable tip microcatheter device. Story
> Survey: Med tech sales reps are out-earning biopharma. Article
Biotech News
@FierceBiotech: AstraZeneca extends global shopping spree with $232M asthma drug deal. More | Follow @FierceBiotech
@JohnCFierce: Kinda wonder why J&J didn't just buy Aduro if it likes its cancer drug work. Maybe that comes next, if it doesn't sour. | Follow @JohnCFierce
@DamianFierce: $GERN's up ~35% on hopes the FDA will release its full clinical hold on PhII cancer studies. News | Follow @DamianFierce
@EmilyMFierce: SARS enzyme finding could help advance MERS vaccine. FierceVaccines story | Follow @EmilyMFierce
> Is the biotech bubble back? Item
> Merck KGaA tackles hot immuno-oncology field in partnership with MorphoSys. Report
> J&J helps bankroll a $55M gamble on partner Aduro's PhIIb cancer drug study. News
Vaccines News
> Mortality dropped, but hospitalizations increased for some in '13-'14 flu season. Report
> Northwest Bio begins German vax trial as glioblastoma market poised to double. More
> Merck's RotaTeq, Glaxo's Rotarix cut hospitalizations by up to 94%. News
> Inovio shares dive on cervical cancer vax speculation. Item
> Dendreon CEO jumps ship as foundering company faces debt pileup. Article
Pharma Manufacturing News
> Teva CFO says company will close about three dozen plants. News
> Germany first in Europe to test database for defeating counterfeits. Item
> Supplier of unprotected foreign-made cancer drugs gets 15-month prison sentence. Report
> Merck sells salt plant in Lehrte to Schüssler Novachem. More
> Supplier of unprotected foreign-made cancer drugs gets 15-month prison sentence. Article
> Japan's Meiji snaps up Indian CMO Medreich for $290M. Story
And Finally... Rates of prediabetes in England are almost as high as those in the U.S., a new study found. Report